Select your investor profile:
This content is only for the selected type of investor.
Institutional investor?
Healthy living: a trend worth investing in
As a society we're spending more on health. For investors that presents new opportunities in the health nutrition biotech and environmental sectors.
We are living for longer, have more leisure time, and are becoming wealthier. And there are more of us inhabiting polluted cities than ever before.
It is no surprise, then, that as a society we’re spending a bigger portion of our income on health. Governments are increasing investment to deal with problems such as age-related illnesses and urban pollution while consumers are spending more on healthier food and leisure activities.
The numbers certainly bear witness to the shift in our priorities. Public spending on health in developed countries has risen by over 2 per cent per annum over the past decade.1
At the same time, sales of healthcare wearable devices are forecast to be 50 times greater in 2018 than they were in 2015,2 while the global organic food market is projected to expand by 14 per cent a year through to 2021.3
Investors should take note. As money flows into health-related industries, investment opportunities are bound to emerge.
That’s where our range of healthy living strategies comes in. Our four health-related investment strategies give investors access to some of the companies we expect to benefit from this powerful, long-term trend.
- The Health strategy aims to identify the most attractive investments in three areas: innovation in the production of new medicines, modernisation of equipment and services and the development of more effective tools and technology. Technological innovation is key, particularly where it drives the falling costs of DNA sequencing and the expansion of computer processing power.
- Companies in the Nutrition strategy are focused on developing solutions to help secure the world’s future food supply, be that through improving farming productivity, reducing food waste or maximising the nutritional content of what we eat.
- Our Biotech portfolio is invested in companies – both small and big – at the forefront of medical innovation. This fast-growing industry uses biological processes, organisms or cells to develop new technologies and medicines. Breakthroughs here can be very profitable.
- Safeguarding the environment is the key theme of the Global Environmental Opportunities (GEO) strategy. Unhealthy environments account for nearly a quarter of all deaths globally, with diseases related to air pollution taking a particularly heavy toll.4 This presents a big opportunity for companies who are developing new ways to safeguard natural resources and reduce pollution.
Health matters to all of us. From improving the quality and sustainability of the food we eat and cleaning the air we breathe to curing our illnesses, innovative companies are helping us live healthier lives. We believe such businesses will be among the most attractive long-term investments in the global equity market. Just as we cannot afford to ignore our own health, investors should not overlook the opportunities presented by the boom in healthy living.
Read more
Important legal information
This marketing document is issued by Pictet Asset Management. It is neither directed to, nor intended for distribution or use by any person or entity who is a citizen or resident of, or domiciled or located in, any locality, state, country or jurisdiction where such distribution, publication, availability or use would be contrary to law or regulation. Only the latest version of the fund’s prospectus, the KIID (Key Investor Information Document), regulations, annual and semi-annual reports may be relied upon as the basis for investment decisions. These documents are available on assetmanagement.pictet.
This document is used for informational purposes only and does not constitute, on Pictet Asset Management part, an offer to buy or sell solicitation or investment advice. It has been established on the basis of data, projections, forecasts, anticipations and hypothesis which are subjective. Its analysis and conclusions are the expression of an opinion, based on available data at a specific date. The effective evolution of the economic variables and values of the financial markets could be significantly different from the indications communicated in this document.
Information, opinions and estimates contained in this document reflect a judgment at the original date of publication and are subject to change without notice. Pictet Asset Management has not taken any steps to ensure that the securities referred to in this document are suitable for any particular investor and this document is not to be relied upon in substitution for the exercise of independent judgment. Tax treatment depends on the individual circumstances of each investor and may be subject to change in the future. Before making any investment decision, investors are recommended to ascertain if this investment is suitable for them in light of their financial knowledge and experience, investment goals and financial situation, or to obtain specific advice from an industry professional.
The value and income of any of the securities or financial instruments mentioned in this document may fall as well as rise and, as a consequence, investors may receive back less than originally invested. Risk factors are listed in the fund’s prospectus and are not intended to be reproduced in full in this document.
Past performance is not a guarantee or a reliable indicator of future performance. Performance data does not include the commissions and fees charged at the time of subscribing for or redeeming shares. This marketing material is not intended to be a substitute for the fund’s full documentation or for any information which investors should obtain from their financial intermediaries acting in relation to their investment in the fund or funds mentioned in this document.
EU countries: the relevant entity is Pictet Asset Management (Europe) S.A., 15, avenue J. F. Kennedy, L-1855 Luxembourg
Switzerland: the relevant entity is Pictet Asset Management SA , 60 Route des Acacias – 1211 Geneva 73
Hong Kong: this material has not been reviewed by the Securities and Futures Commission or any other regulatory authority. The issuer of this material is Pictet Asset Management (Hong Kong) Limited.
Singapore: this material is issued by Pictet Asset Management (Singapore) Pte Ltd. This material is intended only for institutional and accredited investors and it has not been reviewed by the Monetary Authority of Singapore.
For Australian investors, Pictet Asset Management Limited (ARBN 121 228 957) is exempt from the requirement to hold an Australian financial services license, under the Corporations Act 2001.
For US investors, Shares sold in the United States or to US Persons will only be sold in private placements to accredited investors pursuant to exemptions from SEC registration under the Section 4(2) and Regulation D private placement exemptions under the 1933 Act and qualified clients as defined under the 1940 Act. The Shares of the Pictet funds have not been registered under the 1933 Act and may not, except in transactions which do not violate United States securities laws, be directly or indirectly offered or sold in the United States or to any US Person. The Management Fund Companies of the Pictet Group will not be registered under the 1940 Act.
For US investors, Shares sold in the United States or to US Persons will only be sold in private placements to accredited investors pursuant to exemptions from SEC registration under the Section 4(2) and Regulation D private placement exemptions under the 1933 Act and qualified clients as defined under the 1940 Act. The Shares of the Pictet funds have not been registered under the 1933 Act and may not, except in transactions which do not violate United States securities laws, be directly or indirectly offered or sold in the United States or to any US Person. The Management Fund Companies of the Pictet Group will not be registered under the 1940 Act.
Pictet Asset Management Inc. (Pictet AM Inc) is responsible for effecting solicitation in North America to promote the portfolio management services of Pictet Asset Management Limited (Pictet AM Ltd) and Pictet Asset Management SA (Pictet AM SA).
In Canada Pictet AM Inc. is registered as Portfolio Manager authorised to conduct marketing activities on behalf of Pictet AM Ltd and Pictet AM SA. In the USA, Pictet AM Inc. is registered as an SEC Investment Adviser and its activities are conducted in full compliance with the SEC rules applicable to the marketing of affiliate entities as prescribed in the Adviser Act of 1940 ref. 17CFR275.206(4)-3.